{"id":9135,"date":"2018-09-26T14:16:00","date_gmt":"2018-09-26T12:16:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/"},"modified":"2018-09-26T14:16:00","modified_gmt":"2018-09-26T12:16:00","slug":"irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/","title":{"rendered":"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston"},"content":{"rendered":"<p>[mfn_before_post]<\/p>\n<div class=\"mfn-preamble\"><strong>IRLAB:s forskningsplattform, Integrative Screening Process \u2013 ISP, r\u00f6ner ett \u00f6kat internationellt intresse. ISP kommer att presenteras vid konferensen CNS and Neurodegenerative Targets i Boston den 26-27 september 2018.<\/strong><\/div>\n<p>IRLAB \u00e4r inbjudna till konferensen och deltar med presentationen \u201dEvolving the Concept of Phenotypic Screening to a New Level of Data-Driven, Systems Oriented Drug Discovery\u201d. Presentationen h\u00e5lls av Peder Svensson, PhD \u2013 Director of Computational Chemistry &amp; Biology, CIO. Mer information om ISP finns att l\u00e4sa p\u00e5 IRLAB:s webbplats, <a href=\"http:\/\/www.irlab.se\/isp-platform\" rel=\"nofollow\">www.irlab.se\/isp-platform<\/a> och i den publicerade artikeln i ACS Chemical Neuroscience, <a href=\"http:\/\/www.bit.ly\/IRLAB_ACS\" rel=\"nofollow\">www.bit.ly\/IRLAB_ACS<\/a>.<\/p>\n<p>Konferensen syftar till att belysa de senaste forskningsverktygen och -plattformarna som driver dagens strategier f\u00f6r uppt\u00e4ckt av nya l\u00e4kemedel f\u00f6r behandling av hj\u00e4rnans sjukdomar. Mer information finns att l\u00e4sa p\u00e5 konferensens webbplats, <a href=\"http:\/\/www.discoverytarget.com\/CNS-Neurodegenerative-Targets\" rel=\"nofollow\">www.discoverytarget.com\/CNS-Neurodegenerative-Targets<\/a>.<\/p>\n<div class=\"mfn-footer\">\n<p><strong>F\u00f6r vidare information<\/strong><\/p>\n<p>Nicholas Waters, VD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Tel: +46 730 75 77 01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0<br \/>E-post: <a href=\"mailto:nicholas.waters@irlab.se\" rel=\"nofollow\">nicholas.waters@irlab.se<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong>Om IRLAB<\/strong><\/p>\n<p>IRLAB \u00e4r ett forsknings- och utvecklingsbolag, listat p\u00e5 Nasdaq First North Premier som fokuserar p\u00e5 utveckling av nya l\u00e4kemedel f\u00f6r behandling av neurodegenerativa sjukdomar, i synnerhet Parkinsons sjukdom och demens.<\/p>\n<p>IRLAB har tv\u00e5 kliniska l\u00e4kemedelskandidater, IRL752 och IRL790, inriktade mot medicinska behov vid Parkinsons sjukdom, samt ytterligare projekt i preklinisk fas.<\/p>\n<p>IRLAB:s forskning syftar till att uppt\u00e4cka och utveckla nya l\u00e4kemedelskandidater f\u00f6r behandling av hj\u00e4rnans sjukdomar, d\u00e4r stora medicinska behov idag f\u00f6religger. Med hj\u00e4lp av den unika systembiologiska forskningsplattformen, ISP, uppt\u00e4cks dess nya behandlingsprinciper.<\/p>\n<p>IRLAB \u00e4r baserat i G\u00f6teborg. IRLAB:s verksamhet bedrivs huvudsakligen genom dotterbolaget Integrative Research Laboratories Sweden AB.<\/p>\n<p>F\u00f6r mer information, v\u00e4nligen bes\u00f6k\u00a0<a href=\"http:\/\/www.irlab.se\/\" rel=\"nofollow\">www.irlab.se<\/a>.<\/p>\n<\/div>\n<p>[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB:s forskningsplattform, Integrative Screening Process &#8211; ISP, r\u00f6ner ett \u00f6kat internationellt intresse. ISP kommer att presenteras vid konferensen CNS and Neurodegenerative Targets i Boston den 26-27 september 2018.<\/p>\n","protected":false},"template":"","class_list":["post-9135","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB:s forskningsplattform, Integrative Screening Process - ISP, r\u00f6ner ett \u00f6kat internationellt intresse. ISP kommer att presenteras vid konferensen CNS and Neurodegenerative Targets i Boston den 26-27 september 2018.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/\",\"name\":\"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2018-09-26T12:16:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston - IRLAB","og_description":"IRLAB:s forskningsplattform, Integrative Screening Process - ISP, r\u00f6ner ett \u00f6kat internationellt intresse. ISP kommer att presenteras vid konferensen CNS and Neurodegenerative Targets i Boston den 26-27 september 2018.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/","name":"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2018-09-26T12:16:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-isp-vid-konferensen-cns-and-neurodegenerative-targets-i-boston\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar ISP vid konferensen CNS and Neurodegenerative Targets i Boston"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}